Feng He

Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects <i>In Vitro</i> and Neuroprotective Effects in a Pharmacological Alzheimer’s Disease Mouse Model

Feng He, C. James Chou, Matthias Scheiner et al. · Journal of Medicinal Chemistry · 2021 · 57 citations · Full text

Glycyrrhetinic acid-modified graphene oxide mediated siRNA delivery for enhanced liver-cancer targeting therapy

Ying Qu, Feifei Sun, Feng He et al. · European Journal of Pharmaceutical Sciences · 2019 · 51 citations

Nanomedicine, Drug Targeting, Polymer-drug Conjugate +8

Selective Pseudo-irreversible Butyrylcholinesterase Inhibitors Transferring Antioxidant Moieties to the Enzyme Show Pronounced Neuroprotective Efficacy In Vitro and In Vivo in an Alzheimer’s Disease Mouse Model

Matthias Scheiner, Matthias Hoffmann, Feng He et al. · Journal of Medicinal Chemistry · 2021 · 43 citations · Full text

Tacrine-hydroxamate derivatives as multitarget-directed ligands for the treatment of Alzheimer’s disease: Design, synthesis, and biological evaluation

Ana Xu, Feng He, Xiangna Zhang et al. · Bioorganic Chemistry · 2020 · 34 citations

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +10

Design, synthesis and biological evaluation of dual-function inhibitors targeting NMDAR and HDAC for Alzheimer’s disease

Feng He, Yingying Ran, Xiaoyang Li et al. · Bioorganic Chemistry · 2020 · 27 citations

Neurodegenerative Diseases, Alzheimer's Disease, Dual-function Inhibitors +10